What is SRTA's transplant clinical — revenue?

SRTA (SRTA) reported transplant clinical — revenue of $9.84M in Q1 2026.

What does transplant clinical — revenue mean?

This metric represents the total gross revenue generated from the sale of products and services specifically within the Transplant Clinical business segment. It captures the financial performance of clinical solutions tailored for organ transplantation procedures and related patient care workflows. Monitoring this revenue stream provides insight into the company's market penetration and adoption rates within the specialized transplant medical community.

SRTA SRTA Transplant Clinical — Revenue

Other product segments

Other Clinical

$9.95M—

Similar metrics at other companies

TMDXOcs Transplant Revenue — Revenue

$172.67M+21.0%

CDNAProduct revenue — Total Revenue

$10.35M-4.3%

SLPClinical Operations — Revenue

$415K-53.6%

CDNATesting services revenue — Total Revenue

$91.4M+47.6%

MMSClinical Services — Revenue

$530.81M+5.3%

TMDXLiver Product — Revenue

$138.98M+27.7%

Other financials

Income statement

See full

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

See full

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

See full

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

See full

Market cap$463.78M+24.0%

Enterprise value$409.26M—

P/E8.9×—

P/S1.8×—

Profitability

See full

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

See full

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's transplant clinical — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SRTA's transplant clinical — revenue?: SRTA (SRTA) reported transplant clinical — revenue of $9.84M in Q1 2026.
What does transplant clinical — revenue mean?: This metric represents the total gross revenue generated from the sale of products and services specifically within the Transplant Clinical business segment. It captures the financial performance of clinical solutions tailored for organ transplantation procedures and related patient care workflows. Monitoring this revenue stream provides insight into the company's market penetration and adoption rates within the specialized transplant medical community.